Julio Fernandes

8.7k total citations · 1 hit paper
137 papers, 6.9k citations indexed

About

Julio Fernandes is a scholar working on Molecular Biology, Surgery and Pharmacology. According to data from OpenAlex, Julio Fernandes has authored 137 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 42 papers in Surgery and 39 papers in Pharmacology. Recurrent topics in Julio Fernandes's work include Osteoarthritis Treatment and Mechanisms (32 papers), Inflammatory mediators and NSAID effects (31 papers) and RNA Interference and Gene Delivery (27 papers). Julio Fernandes is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (32 papers), Inflammatory mediators and NSAID effects (31 papers) and RNA Interference and Gene Delivery (27 papers). Julio Fernandes collaborates with scholars based in Canada, China and United States. Julio Fernandes's co-authors include Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, Mohamed Benderdour, Qin Shi, Johanne Martel‐Pelletier, Patrick Lavigne, Jean‐Pierre Pelletier, Karin A. Corsi, Dragan Jovanović and Françoise M. Winnik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Julio Fernandes

133 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of cytokines in osteoarthritis pathophysiology

2002 857 citations Julio Fernandes et al. profile →

Peers

Countries citing papers authored by Julio Fernandes

Since Specialization

Citations

This map shows the geographic impact of Julio Fernandes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Fernandes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Fernandes more than expected).

Fields of papers citing papers by Julio Fernandes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julio Fernandes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Fernandes. The network helps show where Julio Fernandes may publish in the future.

Co-authorship network of co-authors of Julio Fernandes

This figure shows the co-authorship network connecting the top 25 collaborators of Julio Fernandes. A scholar is included among the top collaborators of Julio Fernandes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julio Fernandes. Julio Fernandes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets 2025 ·International Journal of Molecular Sciences ·Shabnam Radbakhsh, Mehdi Najar, Makram Merimi, Mohamed Benderdour, Julio Fernandes, Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, Hassan Fahmi	0
2	Use of IMMPACT Recommendations to Explore Pain Phenotypes in People with Knee Osteoarthritis 2022 ·Pain Medicine ·Lisa C. Carlesso, Debbie Ehrmann Feldman, Pascal‐André Vendittoli, Frédéric Lavoie, Manon Choinière, Marie-Ève Bolduc, Julio Fernandes, Nicholas Newman, Pierre Sabouret	10
3	Chitosan-Based Nanogels: Synthesis and Toxicity Profile for Drug Delivery to Articular Joints 2022 ·Nanomaterials ·(unknown), (unknown), Shunmoogum A. Patten, Julio Fernandes, Mohamed Benderdour, Xavier Banquy, Florina Moldovan, Gaëlle Roullin	32
4	Economic evaluation of advanced practice physiotherapy models of care: a systematic review with meta-analyses 2021 ·BMC Health Services Research ·Simon Lafrance, (unknown), Kednapa Thavorn, Julio Fernandes, Carlo Santaguida, François Desmeules	13
5	The pathophysiology of immunoporosis: innovative therapeutic targets 2021 ·Inflammation Research ·(unknown), (unknown), Mohamed Benderdour, Julio Fernandes	19
6	Patient Healthcare Trajectory and its Impact on the Cost-Effectiveness of Fracture Liaison Services 2020 ·Journal of Bone and Mineral Research ·(unknown), Julio Fernandes, J. Delisle, Suzanne N. Morin, Alice Dragomir, (unknown), Sylvie Perreault	13
7	<p>Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications</p> 2020 ·International Journal of Nanomedicine ·(unknown), (unknown), (unknown), Maicon Segalla Petrônio, Márcio José Tiera, Mohamed Benderdour, Julio Fernandes	26
8	Performance of a Fracture Liaison Service in an Orthopaedic Setting 2019 ·Journal of Bone and Joint Surgery ·(unknown), Sylvie Perreault, J. Delisle, Suzanne N. Morin, Julio Fernandes	8
9	In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice 2018 ·International Journal of Nanomedicine ·Qin Shi, (unknown), (unknown), Márcio José Tiera, Xiaoling Zhang, Kerong Dai, (unknown), Mohamed Benderdour, Julio Fernandes	62
10	The impact of a standardized order set for the management of non-hip fragility fractures in a Fracture Liaison Service 2016 ·Osteoporosis International ·(unknown), J. Delisle, (unknown), (unknown), Stéphane Leduc, Michel Malo, Hai Nguyen, Pierre Ranger, Julio Fernandes	7
11	Agreement between physicians’ and nurses’ clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone™ program 2015 ·Osteoporosis International ·(unknown), J. Delisle, J.-P. Raynauld, Suzanne N. Morin, Julio Fernandes	12
12	Polyethylenimine600-β-cyclodextrin: a promising nanopolymer for nonviral gene delivery of primary mesenchymal stem cells 2013 ·International Journal of Nanomedicine ·Haijun Tong, Mingxuan Wang, Qin Shi, Julio Fernandes, (unknown), Guping Tang, (unknown), Yü Huang	15
13	Physicochemical characterization of nanoparticles formed between DNA and phosphorylcholine substituted chitosans 2009 ·Journal of Colloid and Interface Science ·(unknown), (unknown), Maria Elisabete Darbello Zaniquelli, Julio Fernandes, Sebastião Roberto Taboga, Françoise M. Winnik, Márcio José Tiera	20
14	Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients 2006 ·Osteoarthritis and Cartilage ·Qin Shi, Mohamed Benderdour, Patrick Lavigne, Pierre Ranger, Julio Fernandes	12
15	Characterization of folate-chitosan-DNA nanoparticles for gene therapy 2005 ·Biomaterials ·(unknown), Cuie Yan, Françoise M. Winnik, Qin Shi, Patrick Lavigne, Mohamed Benderdour, Éric Beaumont, Julio Fernandes	317
16	Subchondral and trabecular bone metabolism regulation in canine experimental knee osteoarthritis 2005 ·Osteoarthritis and Cartilage ·Patrick Lavigne, Mohamed Benderdour, Daniel Lajeunesse, Pascal Reboul, Qin Shi, J.-P. Pelletier, Johanne Martel‐Pelletier, Julio Fernandes	41
17	Knee dislocations: experience at the Hôpital du Sacré-Coeur de Montréal. 2004 ·PubMed ·Max Talbot, Greg Berry, Julio Fernandes, Pierre Ranger	38
18	Carprofen reduces the structural changes and the abnormal subchondral bone metabolism of experimental osteoarthritis 1999 ·Osteoarthritis and Cartilage ·Jean-Pierre Pelletier, Daniel Lajeunesse, (unknown), Dragan Jovanović, Julio Fernandes, Johanne Martel‐Pelletier	16
19	Pharmacologic therapy of osteoarthritis 1999 ·Current Rheumatology Reports ·Jean-Pierre Pelletier, D. Choquette, Boulos Haraoui, Jean‐Pierre Raynauld, Éric Rich, Julio Fernandes, Johanne Martel‐Pelletier	4
20	In vivo suppression of early experimental osteoarthritis by interleukin‐1 receptor antagonist using gene therapy 1997 ·Arthritis & Rheumatism ·Jean‐Pierre Pelletier, John P. Caron, Christopher H. Evans, Paul D. Robbins, H. I. Georgescu, Dragan Jovanović, Julio Fernandes, Johanne Martel‐Pelletier	288

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact